The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma-Reference-Cited by-同舟云学术

The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma

Published:2014-03-05 Issue:8 Volume:93 Page:1297-1304
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Avigdor Abraham,Sirotkin Tsvi,Kedmi Meirav,Ribakovsy Elena,Berkowicz Miriam,Davidovitz Yaron,Kneller Abraham,Merkel Drorit,Volchek Yulia,Davidson Tima,Goshen Elinor,Apter Sara,Shimoni Avichai,Ben-Bassat Isaac,Nagler Arnon

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2043-y.pdf

Reference33 articles.

1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117(19):5019–5032. doi: 10.1182/blood-2011-01-293050

2. Swerdlow SHCE, Harris NL et al (2008) Classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon

3. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M, Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt LM (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198(6):851–862. doi: 10.1084/jem.20031074

4. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, Aguiar RC, Li S, Salles G, Berger F, Jing W, Pinkus GS, Habermann T, Dalla-Favera R, Harris NL, Aster JC, Golub TR, Shipp MA (2003) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102(12):3871–3879. doi: 10.1182/blood-2003-06-1841

5. Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM (2006) Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 17(1):123–130. doi: 10.1093/annonc/mdj030

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Результаты терапии первичной медиастинальной В-крупноклеточной лимфомы. Опыт МРНЦ им. А.Ф. Цыба (Обнинск);Clinical Oncohematology;2024-07-01

2. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4068 patients;Haematologica;2023-08-31

4. Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma;Hematology;2023-06

5. Interim FDG-PET/CT for Response Assessment of Lymphoma;Seminars in Nuclear Medicine;2023-05